US-based health technology company Allurion Technologies has entered commercial agreements with two aesthetic and weight loss clinic chains, Lazeo in France and UK-based company Transform.
Through these agreements, Allurion aims to expand its Virtual Care Suite (VCS) digital platform, a comprehensive toolkit designed to enhance functionality for weight loss practices.
The partnerships come after Allurion expanded its collaboration with Weight Doctors, a Germany-based private clinic group for weight loss.
Allurion said its accelerated growth of VCS through strategic partnerships highlights increasing opportunities for the digital platform since the launch of Coach Iris, Allurion’s 24/7 AI-powered weight loss coach, in October last year.
The company has also said that the integration of Coach Iris into VCS has provided round-the-clock coaching and guidance for patients undergoing various weight loss treatments, including anti-obesity medications, devices and bariatric surgery.
In France, Lazeo has implemented the VCS within their Allurion Program and Nutricare by Lazeo, a dietitian-supervised nutrition programme that takes place over three, six or 12 months.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
This is claimed to have led to improved patient engagement, streamlined workflows and better patient outcomes.
In the UK, Transform has adopted the VCS to enhance the patient care experience for those enrolled in their Allurion programme and undergoing bariatric surgery.
According to an Allurion study, a significant majority of providers using VCS have reported benefits such as increased patient accountability and heightened patient engagement.
Clinics with the highest usage rates of VCS have reportedly also seen an average of 11% additional weight loss in their patients.
Allurion founder and CEO Dr Shantanu Gaur said: Our growing partnerships with industry leaders like Lazeo and Transform demonstrate the power and versatility of the Virtual Care Suite.
“As we continue to improve Coach Iris, we are confident in our ability to scale our VCS business while providing unmatched support to patients and empowering healthcare providers on the frontlines of obesity care.”